Document is current
Any future updates will be listed below
-
Authors
Wittert, Gary https://orcid.org/0000-0001-6818-6065
Grossmann, Mathis
-
Funding
Funding for this research was provided by:
The University of Adelaide
- License Information
-
More Information
Article History
Accepted: 23 June 2022
First Online: 14 July 2022
Declarations
:
: No funding has been received.
: GW has received research support from Bayer, Lawley Pharmaceuticals and Eli Lilly. Honoraria for participation in advisory boards have been received from Bayer and Elsevier, Speaker fees have been received from Bayer and Besins Health Care. MG has received research funding from Bayer and Otsuka. He has received fees for advisory board participation form Bayer and Otsuka, and speaker fees from Bayer, Besins Health Care and Novartis. This is a review. There is no requirement for ethical approval. To the best of my knowledge the studies cited have had appropriate ethics approval. This is a review. To the best of my knowledge the studies cited have obtained informed consent. Relative contributions of the Authors to this work: GW 80%, MG 20%.
